Global Nanobiotechnology Market Growth (Status and Outlook) 2024-2030

2024

Global Nanobiotechnology Market Growth (Status and Outlook) 2024-2030

Name: Global Nanobiotechnology Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001452
Price: 3450 USD
Availability: InStock
Rating: 5 (15.7 reviews)

The global Nanobiotechnology market, valued at US$ 65,760 million in 2023, is growing as advancements in nanotechnology offer new possibilities in medicine, healthcare, and environ

Bonafide Trust
10-09-2024
Pages : 161
Figures : 81
Tables : 152
Region : Global
Category : Lifescience & Healthcare
Biotechnology

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global nanobiotechnology market is a rapidly growing sector, driven by the convergence of nanotechnology and biotechnology to create innovative solutions for various industries. Nanobiotechnology involves the application of nanoscale materials, devices, and techniques to understand, interact with, and control biological processes, leading to advancements in medicine, agriculture, environmental science, and more. In the healthcare sector, nanobiotechnology is transforming disease diagnosis and treatment, with nanoparticles being used for targeted drug delivery and rapid diagnostic tools. The market is segmented by nanoparticles, nanodevices, nano biopharmaceuticals, and applications in medicine, diagnostics, biological imaging, agriculture, and environmental nanobiotechnology. North America leads the market, driven by significant investments in research and development, while Asia-Pacific is expected to experience the fastest growth due to rapid industrialization and increasing healthcare needs. The continuous advancements in nanomaterials and fabrication techniques are expected to further propel the market, making nanobiotechnology a key player in the future of scientific innovation and industrial applications.

According to Publisher, the global Nanobiotechnology market size was valued at US$ 65760 million in 2023. With growing demand in downstream market, the Nanobiotechnology is forecast to a readjusted size of US$ 101810 million by 2030 with a CAGR of 6.4% during review period. The global nanobiotechnology market is experiencing significant growth, driven by several key factors. Advancements in nanotechnology research and development are a major driver, as continuous innovations in nanomaterials and nanofabrication techniques open up new possibilities for applications in healthcare, agriculture, and environmental science. The increasing prevalence of chronic diseases and the need for early detection and targeted treatment are also propelling market growth. Rising investments in research and development (R&D) from both the public and private sectors are fostering the development of novel nanobiotechnology solutions, leading to breakthroughs in diagnostics, therapeutics, and biomedical research. Additionally, the integration of nanotechnology in healthcare is enhancing the precision and effectiveness of medical treatments, such as targeted drug delivery systems and rapid diagnostic tools. The growing demand for personalized medicine and the need for customized treatment plans further drive the adoption of nanobiotechnology. As the global population continues to grow and the demand for advanced healthcare solutions increases, the nanobiotechnology market is expected to expand significantly, supported by technological advancements and increasing investments in R&D. Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics. The global nanobiotechnology market is segmented by type into nanoparticles, nanodevices, nanobiopharmaceuticals, and applications in medicine. Nanoparticles include metal nanoparticles, polymeric nanoparticles, and liposomal nanoparticles, each offering unique properties for various applications. Metal nanoparticles are widely used in medical imaging and drug delivery due to their unique optical and magnetic properties. Polymeric nanoparticles are employed in controlled drug release systems, while liposomal nanoparticles are utilized for targeted drug delivery and gene therapy. Nanodevices encompass nanosensors, nanochips, and nanorobots, which are integral to advanced diagnostics and therapeutic interventions. Nanosensors detect biological molecules with high sensitivity; nanochips are used in genetic analysis and disease detection; and nanorobots are being developed for precision surgery and targeted drug delivery. Nanobiopharmaceuticals include nanodrugs and nano-based vaccines, which offer enhanced efficacy and reduced side effects compared to conventional pharmaceuticals. Nanodrugs improve drug solubility and bioavailability, while nano-based vaccines provide robust immune responses with lower doses. Applications in medicine cover cancer nanomedicine, neurological disorders, cardiovascular nanomedicine, and more. These applications leverage nanotechnology to develop innovative treatments and diagnostic tools, addressing unmet medical needs and improving patient outcomes. The continuous advancements in nanomaterials and fabrication techniques are expected to further propel the market, making nanobiotechnology a key player in the future of scientific innovation and industrial applications.

The global nanobiotechnology market is segmented by application into medical, agricultural, environmental, and industrial applications. In the medical segment, nanobiotechnology is revolutionizing healthcare through advanced diagnostics, targeted drug delivery systems, and regenerative medicine. Nanoparticles and nanodevices are being used to detect diseases at early stages, deliver drugs directly to affected cells, and create scaffolds for tissue engineering. The agricultural segment benefits from nanobiotechnology through the development of nanofertilizers and nanopesticides, which enhance crop yield and reduce environmental impact. These advanced materials improve nutrients delivery and pest control, leading to more sustainable agricultural practices. In the environmental segment, nanobiotechnology is applied in pollution control and remediation, with nanomaterials being used to remove contaminants from water and soil. These materials offer high efficiency and specificity in capturing pollutants, contributing to cleaner environments. The industrial segment includes applications in manufacturing and materials science, where nanobiotechnology is used to create stronger, lighter, and more durable materials. These advancements are driving innovation across various industries, leading to improved product performance and sustainability. Each application segment reflects the diverse potential of nanobiotechnology to address critical challenges and enhance efficiency in multiple fields, driving the market's growth and evolution.

The global nanobiotechnology market exhibits significant regional variations, reflecting diverse economic, regulatory, and industrial landscapes. North America leads the market, driven by advanced healthcare infrastructure, substantial investments in research and development, and a strong focus on innovation. The United States and Canada are key players, with numerous universities and research institutions contributing to advancements in nanobiotechnology. Europe follows closely, with countries like Germany, the United Kingdom, and France leveraging cutting-edge technologies and stringent regulatory standards to enhance medical and industrial applications. The Asia-Pacific region is the fastest-growing market, fueled by rapid industrialization, increasing healthcare needs, and rising investments in nanotechnology research. Countries such as China, India, and Japan are making significant strides in developing nanobiotechnology solutions for healthcare, agriculture, and environmental applications. South America and the Middle East also show promising growth, driven by expanding healthcare sectors and strategic investments in nanotechnology. Africa, while still emerging, presents opportunities for market expansion as countries invest in modernizing their healthcare systems and improving access to advanced medical technologies. These regional dynamics highlight the global nanobiotechnology market's adaptability and responsiveness to local needs and trends, ensuring its continued growth and evolution.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanobiotechnology Market Size 2019-2030
2.1.2 Nanobiotechnology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nanobiotechnology Segment by Type
2.2.1 Nanomedicine
2.2.2 Nano Medical Devices
2.2.3 Nano Diagnosis
2.2.4 Other
2.3 Nanobiotechnology Market Size by Type
2.3.1 Nanobiotechnology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nanobiotechnology Market Size Market Share by Type (2019-2024)
2.4 Nanobiotechnology Segment by Application
2.4.1 Anticancer
2.4.2 CNS Product
2.4.3 Anti-infective
2.4.4 Other
2.5 Nanobiotechnology Market Size by Application
2.5.1 Nanobiotechnology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nanobiotechnology Market Size Market Share by Application (2019-2024)
3 Nanobiotechnology Market Size by Player
3.1 Nanobiotechnology Market Size Market Share by Players
3.1.1 Global Nanobiotechnology Revenue by Players (2019-2024)
3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2019-2024)
3.2 Global Nanobiotechnology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nanobiotechnology by Regions
4.1 Nanobiotechnology Market Size by Regions (2019-2024)
4.2 Americas Nanobiotechnology Market Size Growth (2019-2024)
4.3 APAC Nanobiotechnology Market Size Growth (2019-2024)
4.4 Europe Nanobiotechnology Market Size Growth (2019-2024)
4.5 Middle East & Africa Nanobiotechnology Market Size Growth (2019-2024)
5 Americas
5.1 Americas Nanobiotechnology Market Size by Country (2019-2024)
5.2 Americas Nanobiotechnology Market Size by Type (2019-2024)
5.3 Americas Nanobiotechnology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nanobiotechnology Market Size by Region (2019-2024)
6.2 APAC Nanobiotechnology Market Size by Type (2019-2024)
6.3 APAC Nanobiotechnology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nanobiotechnology by Country (2019-2024)
7.2 Europe Nanobiotechnology Market Size by Type (2019-2024)
7.3 Europe Nanobiotechnology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nanobiotechnology by Region (2019-2024)
8.2 Middle East & Africa Nanobiotechnology Market Size by Type (2019-2024)
8.3 Middle East & Africa Nanobiotechnology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nanobiotechnology Market Forecast
10.1 Global Nanobiotechnology Forecast by Regions (2025-2030)
10.1.1 Global Nanobiotechnology Forecast by Regions (2025-2030)
10.1.2 Americas Nanobiotechnology Forecast
10.1.3 APAC Nanobiotechnology Forecast
10.1.4 Europe Nanobiotechnology Forecast
10.1.5 Middle East & Africa Nanobiotechnology Forecast
10.2 Americas Nanobiotechnology Forecast by Country (2025-2030)
10.2.1 United States Nanobiotechnology Market Forecast
10.2.2 Canada Nanobiotechnology Market Forecast
10.2.3 Mexico Nanobiotechnology Market Forecast
10.2.4 Brazil Nanobiotechnology Market Forecast
10.3 APAC Nanobiotechnology Forecast by Region (2025-2030)
10.3.1 China Nanobiotechnology Market Forecast
10.3.2 Japan Nanobiotechnology Market Forecast
10.3.3 Korea Nanobiotechnology Market Forecast
10.3.4 Southeast Asia Nanobiotechnology Market Forecast
10.3.5 India Nanobiotechnology Market Forecast
10.3.6 Australia Nanobiotechnology Market Forecast
10.4 Europe Nanobiotechnology Forecast by Country (2025-2030)
10.4.1 Germany Nanobiotechnology Market Forecast
10.4.2 France Nanobiotechnology Market Forecast
10.4.3 UK Nanobiotechnology Market Forecast
10.4.4 Italy Nanobiotechnology Market Forecast
10.4.5 Russia Nanobiotechnology Market Forecast
10.5 Middle East & Africa Nanobiotechnology Forecast by Region (2025-2030)
10.5.1 Egypt Nanobiotechnology Market Forecast
10.5.2 South Africa Nanobiotechnology Market Forecast
10.5.3 Israel Nanobiotechnology Market Forecast
10.5.4 Turkey Nanobiotechnology Market Forecast
10.5.5 GCC Countries Nanobiotechnology Market Forecast
10.6 Global Nanobiotechnology Forecast by Type (2025-2030)
10.7 Global Nanobiotechnology Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Nanobiotechnology Product Offered
11.1.3 Amgen Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Information
11.2.2 Teva Pharmaceuticals Nanobiotechnology Product Offered
11.2.3 Teva Pharmaceuticals Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Teva Pharmaceuticals Main Business Overview
11.2.5 Teva Pharmaceuticals Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Nanobiotechnology Product Offered
11.3.3 Abbott Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 UCB
11.4.1 UCB Company Information
11.4.2 UCB Nanobiotechnology Product Offered
11.4.3 UCB Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 UCB Main Business Overview
11.4.5 UCB Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Nanobiotechnology Product Offered
11.5.3 Roche Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Celgene
11.6.1 Celgene Company Information
11.6.2 Celgene Nanobiotechnology Product Offered
11.6.3 Celgene Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Celgene Main Business Overview
11.6.5 Celgene Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Nanobiotechnology Product Offered
11.7.3 Sanofi Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Merck & Co
11.8.1 Merck & Co Company Information
11.8.2 Merck & Co Nanobiotechnology Product Offered
11.8.3 Merck & Co Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck & Co Main Business Overview
11.8.5 Merck & Co Latest Developments
11.9 Biogen
11.9.1 Biogen Company Information
11.9.2 Biogen Nanobiotechnology Product Offered
11.9.3 Biogen Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Biogen Main Business Overview
11.9.5 Biogen Latest Developments
11.10 Stryker
11.10.1 Stryker Company Information
11.10.2 Stryker Nanobiotechnology Product Offered
11.10.3 Stryker Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Stryker Main Business Overview
11.10.5 Stryker Latest Developments
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Information
11.11.2 Gilead Sciences Nanobiotechnology Product Offered
11.11.3 Gilead Sciences Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Gilead Sciences Main Business Overview
11.11.5 Gilead Sciences Latest Developments
11.12 Pfizer
11.12.1 Pfizer Company Information
11.12.2 Pfizer Nanobiotechnology Product Offered
11.12.3 Pfizer Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Pfizer Main Business Overview
11.12.5 Pfizer Latest Developments
11.13 3M Company
11.13.1 3M Company Company Information
11.13.2 3M Company Nanobiotechnology Product Offered
11.13.3 3M Company Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 3M Company Main Business Overview
11.13.5 3M Company Latest Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Information
11.14.2 Johnson & Johnson Nanobiotechnology Product Offered
11.14.3 Johnson & Johnson Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Johnson & Johnson Main Business Overview
11.14.5 Johnson & Johnson Latest Developments
11.15 Smith & Nephew
11.15.1 Smith & Nephew Company Information
11.15.2 Smith & Nephew Nanobiotechnology Product Offered
11.15.3 Smith & Nephew Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Smith & Nephew Main Business Overview
11.15.5 Smith & Nephew Latest Developments
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Information
11.16.2 Leadiant Biosciences Nanobiotechnology Product Offered
11.16.3 Leadiant Biosciences Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Leadiant Biosciences Main Business Overview
11.16.5 Leadiant Biosciences Latest Developments
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Information
11.17.2 Kyowa Hakko Kirin Nanobiotechnology Product Offered
11.17.3 Kyowa Hakko Kirin Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Kyowa Hakko Kirin Main Business Overview
11.17.5 Kyowa Hakko Kirin Latest Developments
11.18 Shire
11.18.1 Shire Company Information
11.18.2 Shire Nanobiotechnology Product Offered
11.18.3 Shire Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Shire Main Business Overview
11.18.5 Shire Latest Developments
11.19 Ipsen
11.19.1 Ipsen Company Information
11.19.2 Ipsen Nanobiotechnology Product Offered
11.19.3 Ipsen Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Ipsen Main Business Overview
11.19.5 Ipsen Latest Developments
11.20 Endo International
11.20.1 Endo International Company Information
11.20.2 Endo International Nanobiotechnology Product Offered
11.20.3 Endo International Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Endo International Main Business Overview
11.20.5 Endo International Latest Developments
12 Research Findings and Conclusion

Table 1. Nanobiotechnology Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Nanomedicine
Table 3. Major Players of Nano Medical Devices
Table 4. Major Players of Nano Diagnosis
Table 5. Major Players of Other
Table 6. Nanobiotechnology Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Nanobiotechnology Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Nanobiotechnology Market Size Market Share by Type (2019-2024)
Table 9. Nanobiotechnology Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Nanobiotechnology Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Nanobiotechnology Market Size Market Share by Application (2019-2024)
Table 12. Global Nanobiotechnology Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Nanobiotechnology Revenue Market Share by Player (2019-2024)
Table 14. Nanobiotechnology Key Players Head office and Products Offered
Table 15. Nanobiotechnology Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nanobiotechnology Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Nanobiotechnology Market Size Market Share by Regions (2019-2024)
Table 20. Global Nanobiotechnology Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Nanobiotechnology Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Nanobiotechnology Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Nanobiotechnology Market Size Market Share by Country (2019-2024)
Table 24. Americas Nanobiotechnology Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Nanobiotechnology Market Size Market Share by Type (2019-2024)
Table 26. Americas Nanobiotechnology Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Nanobiotechnology Market Size Market Share by Application (2019-2024)
Table 28. APAC Nanobiotechnology Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Nanobiotechnology Market Size Market Share by Region (2019-2024)
Table 30. APAC Nanobiotechnology Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Nanobiotechnology Market Size Market Share by Type (2019-2024)
Table 32. APAC Nanobiotechnology Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Nanobiotechnology Market Size Market Share by Application (2019-2024)
Table 34. Europe Nanobiotechnology Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Nanobiotechnology Market Size Market Share by Country (2019-2024)
Table 36. Europe Nanobiotechnology Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Nanobiotechnology Market Size Market Share by Type (2019-2024)
Table 38. Europe Nanobiotechnology Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Nanobiotechnology Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Nanobiotechnology Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Nanobiotechnology Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Nanobiotechnology Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Nanobiotechnology Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Nanobiotechnology Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Nanobiotechnology Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Nanobiotechnology
Table 47. Key Market Challenges & Risks of Nanobiotechnology
Table 48. Key Industry Trends of Nanobiotechnology
Table 49. Global Nanobiotechnology Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Nanobiotechnology Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Nanobiotechnology Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Nanobiotechnology Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Amgen Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 54. Amgen Nanobiotechnology Product Offered
Table 55. Amgen Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Amgen Main Business
Table 57. Amgen Latest Developments
Table 58. Teva Pharmaceuticals Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 59. Teva Pharmaceuticals Nanobiotechnology Product Offered
Table 60. Teva Pharmaceuticals Main Business
Table 61. Teva Pharmaceuticals Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Teva Pharmaceuticals Latest Developments
Table 63. Abbott Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 64. Abbott Nanobiotechnology Product Offered
Table 65. Abbott Main Business
Table 66. Abbott Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Abbott Latest Developments
Table 68. UCB Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 69. UCB Nanobiotechnology Product Offered
Table 70. UCB Main Business
Table 71. UCB Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. UCB Latest Developments
Table 73. Roche Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 74. Roche Nanobiotechnology Product Offered
Table 75. Roche Main Business
Table 76. Roche Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Roche Latest Developments
Table 78. Celgene Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 79. Celgene Nanobiotechnology Product Offered
Table 80. Celgene Main Business
Table 81. Celgene Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Celgene Latest Developments
Table 83. Sanofi Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 84. Sanofi Nanobiotechnology Product Offered
Table 85. Sanofi Main Business
Table 86. Sanofi Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Sanofi Latest Developments
Table 88. Merck & Co Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 89. Merck & Co Nanobiotechnology Product Offered
Table 90. Merck & Co Main Business
Table 91. Merck & Co Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Merck & Co Latest Developments
Table 93. Biogen Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 94. Biogen Nanobiotechnology Product Offered
Table 95. Biogen Main Business
Table 96. Biogen Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Biogen Latest Developments
Table 98. Stryker Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 99. Stryker Nanobiotechnology Product Offered
Table 100. Stryker Main Business
Table 101. Stryker Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Stryker Latest Developments
Table 103. Gilead Sciences Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 104. Gilead Sciences Nanobiotechnology Product Offered
Table 105. Gilead Sciences Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Gilead Sciences Main Business
Table 107. Gilead Sciences Latest Developments
Table 108. Pfizer Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 109. Pfizer Nanobiotechnology Product Offered
Table 110. Pfizer Main Business
Table 111. Pfizer Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Pfizer Latest Developments
Table 113. 3M Company Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 114. 3M Company Nanobiotechnology Product Offered
Table 115. 3M Company Main Business
Table 116. 3M Company Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. 3M Company Latest Developments
Table 118. Johnson & Johnson Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 119. Johnson & Johnson Nanobiotechnology Product Offered
Table 120. Johnson & Johnson Main Business
Table 121. Johnson & Johnson Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Johnson & Johnson Latest Developments
Table 123. Smith & Nephew Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 124. Smith & Nephew Nanobiotechnology Product Offered
Table 125. Smith & Nephew Main Business
Table 126. Smith & Nephew Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Smith & Nephew Latest Developments
Table 128. Leadiant Biosciences Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 129. Leadiant Biosciences Nanobiotechnology Product Offered
Table 130. Leadiant Biosciences Main Business
Table 131. Leadiant Biosciences Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Leadiant Biosciences Latest Developments
Table 133. Kyowa Hakko Kirin Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 134. Kyowa Hakko Kirin Nanobiotechnology Product Offered
Table 135. Kyowa Hakko Kirin Main Business
Table 136. Kyowa Hakko Kirin Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Kyowa Hakko Kirin Latest Developments
Table 138. Shire Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 139. Shire Nanobiotechnology Product Offered
Table 140. Shire Main Business
Table 141. Shire Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Shire Latest Developments
Table 143. Ipsen Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 144. Ipsen Nanobiotechnology Product Offered
Table 145. Ipsen Main Business
Table 146. Ipsen Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Ipsen Latest Developments
Table 148. Endo International Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 149. Endo International Nanobiotechnology Product Offered
Table 150. Endo International Main Business
Table 151. Endo International Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Endo International Latest Developments
List of

Figure 1. Nanobiotechnology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nanobiotechnology Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nanobiotechnology Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nanobiotechnology Sales Market Share by Country/Region (2023)
Figure 8. Nanobiotechnology Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nanobiotechnology Market Size Market Share by Type in 2023
Figure 10. Nanobiotechnology in Anticancer
Figure 11. Global Nanobiotechnology Market: Anticancer (2019-2024) & ($ Millions)
Figure 12. Nanobiotechnology in CNS Product
Figure 13. Global Nanobiotechnology Market: CNS Product (2019-2024) & ($ Millions)
Figure 14. Nanobiotechnology in Anti-infective
Figure 15. Global Nanobiotechnology Market: Anti-infective (2019-2024) & ($ Millions)
Figure 16. Nanobiotechnology in Other
Figure 17. Global Nanobiotechnology Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Nanobiotechnology Market Size Market Share by Application in 2023
Figure 19. Global Nanobiotechnology Revenue Market Share by Player in 2023
Figure 20. Global Nanobiotechnology Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Nanobiotechnology Market Size 2019-2024 ($ Millions)
Figure 22. APAC Nanobiotechnology Market Size 2019-2024 ($ Millions)
Figure 23. Europe Nanobiotechnology Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Nanobiotechnology Market Size 2019-2024 ($ Millions)
Figure 25. Americas Nanobiotechnology Value Market Share by Country in 2023
Figure 26. United States Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Nanobiotechnology Market Size Market Share by Region in 2023
Figure 31. APAC Nanobiotechnology Market Size Market Share by Type in 2023
Figure 32. APAC Nanobiotechnology Market Size Market Share by Application in 2023
Figure 33. China Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Nanobiotechnology Market Size Market Share by Country in 2023
Figure 40. Europe Nanobiotechnology Market Size Market Share by Type (2019-2024)
Figure 41. Europe Nanobiotechnology Market Size Market Share by Application (2019-2024)
Figure 42. Germany Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Nanobiotechnology Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Nanobiotechnology Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Nanobiotechnology Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Nanobiotechnology Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 56. APAC Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 57. Europe Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 59. United States Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 60. Canada Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 63. China Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 64. Japan Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 65. Korea Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 67. India Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 68. Australia Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 69. Germany Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 70. France Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 71. UK Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 72. Italy Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 73. Russia Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 74. Spain Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 77. Israel Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Nanobiotechnology Market Size 2025-2030 ($ Millions)
Figure 80. Global Nanobiotechnology Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Nanobiotechnology Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted